Infectious Disease and Primary Care
Research activity includes community-based care for COVID-19 in general practice, with attention to patients at higher risk of a complicated illness course and to treatment options that support recovery in the outpatient setting.
- COVID-19 management in the community
- Primary care treatment pathways
- High-risk outpatient respiratory infection
The portfolio also reflects interest in building clinical research capacity within Dutch primary care for future infectious disease studies.
Mental Health and Neurostimulation
Clinical research covers major depressive disorder and attention deficit hyperactivity disorder, with studies focused on symptom control, emotional regulation, sleep, and treatment augmentation strategies.
- Major depressive disorder
- Attention deficit hyperactivity disorder
- Transcranial magnetic stimulation
- Serotonergic microdosing
These areas indicate an interest in psychiatric interventions that combine neuromodulation and emerging pharmacological approaches.
Pain and Neuromodulatory Therapies
The sponsor supports studies in fibromyalgia and metastatic bone pain, with work centered on pain perception, analgesic support, and treatment options for persistent or cancer-related pain syndromes.
- Fibromyalgia
- Metastatic bone pain
- Opioid adjunct therapy
- Pain perception
Interest also extends to psilocybin and other neuroactive agents in the context of chronic pain.
Gastroenterology and Inflammatory Bowel Disease
Research includes Crohn’s disease, with attention to treatment strategies for newly diagnosed patients and long-term disease control in inflammatory bowel disease.
- Crohn’s disease
- Inflammatory bowel disease
- Anti-inflammatory treatment pathways
This area highlights clinical interest in therapeutic sequencing and disease management in gastrointestinal inflammation.
Metabolic Disease and Oncology
Additional trials address type 2 diabetes and solid tumors with DNA damage repair deficiency, including cancers associated with homologous recombination deficiency and Fanconi anemia pathways.
- Type 2 diabetes
- Solid tumors
- Homologous recombination deficiency
- Fanconi anemia
These studies span glucose metabolism and targeted approaches in oncology.
